Autoimmune Lymphoproliferative Syndrome (ALPS) is a rare disorder of immune regulation that arises from genetic mutations principally affecting the Fas-mediated apoptotic pathway. This defect results ...
ITK inhibition intended to address dysregulation of T cells that causes ALPS and has been shown to be effective at treating the disease in preclinical models BURLINGAME, Calif., March 12, 2025 (GLOBE ...
Corvus Pharmaceuticals has announced the initiation of a Phase 2 clinical trial for soquelitinib, an investigational drug, to treat autoimmune lymphoproliferative syndrome (ALPS), a rare genetic ...
In the case of an autoimmune disease, the immune system not only attacks pathogens, but also the body's own cells. Researchers at the University of Freiburg—Medical Center have now been able to show ...
Attendees will see some common applications of cell sorting in a department of immunology. Beginning with an introduction of lymphoproliferative disorders in inborn errors of immunity. 1. How cell ...
ALPS Has Just About 500 Patients Worldwide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results